From USFDA
Strides Shasun announced that its wholly owned subsidiary Strides Pharma Globe has received approval for Tenofovir Disoproxil Fumarate Tablets, 300 mg from the United States Food & Drug Administration.Tenofovir Disoproxil Fumarate is a generic version of Gileads's Viread Tablet, for which patent expired on 25 January 2018. Strides is launching the product immediately.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content